Loading...

PROCEPT BioRobotics Corporation

PRCT•NASDAQ
Healthcare
Medical - Devices
$24.36
$0.12(0.50%)
U.S. Market opens in 30h 27m

PROCEPT BioRobotics Corporation (PRCT) Stock Overview

Explore PROCEPT BioRobotics Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-14.04
EPS (TTM)$-1.72
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$25.07
3 Months$17.21
1 Year Target$0.00

PRCT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of PROCEPT BioRobotics Corporation (PRCT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.04 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.50%
5-Day Change
-1.34%
1-Month Change
-2.95%
3-Month Change
-16.37%
6-Month Change
-30.38%
Year-to-Date (YTD) Change
-22.57%
1-Year Change
-53.65%
3-Year Change
-31.28%
5-Year Change
-41.92%
All-Time (Max) Change
-41.92%

Contact Information

https://www.procept-biorobotics.com
650 232 7200
900 Island Drive, San Jose, CA, 94065

Company Facts

756 Employees
IPO DateSep 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions